What are the indications for CPAP therapy?（Ⅰ）
Positive Airway Pressure (PAP) is a respiratory ventilation mode used to treat sleep-related breathing disorders. It delivers pressurized air through a nasal mask or full-face mask to the lung airways, preventing airway collapse during inhalation. The CPAP therapy is widely recommended because of its effectiveness. Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) are the two most common forms of PAP, typically used to treat sleep apnea.
Generally, patients need the doctor to recommend a suitable CPAP machine to reduce low adherence due to comfort or treatment effectiveness. Below, we will discuss CPAP and BiPAP therapies, their characteristics, indications, and optimal use scenarios.
I.CPAP vs BiPAP: What is the difference
CPAP (continuous positive airway pressure) is a small ventilator that provides a single, constant positive pressure throughout the sleep cycle.This device continuously delivers filtered, pressurized air at a comfortable temperature to the mouth or nose through a mask. It keeps the upper airway open, preventing the tongue, uvula, and soft palate from collapsing and blocking the airway. It is important to note that CPAP delivers only unidirectional airflow. Therefore, it is essential to ensure that patients using CPAP retain the ability to breathe spontaneously.
BiPAP (Bilevel Positive Airway Pressure) is a non-invasive respiratory assist device that provides two different pressure levels:
• IPAP (Inhalation Positive Airway Pressure) — higher pressure to assist inhalation
• EPAP (Exhalation Positive Airway Pressure) — lower pressure to reduce respiratory effort during exhalation
BiPAP can be set to a time-cycled mode (S/T mode) for patients with hypoventilation, or it can automatically adjust pressure based on the patient’s breathing pattern (S mode) to adapt to the patient’s natural breathing rhythm. Therefore, while most patients with sleep apnea are recommended to use CPAP, a small number still require BiPAP machine, particularly those with central sleep apnea.
II.Comparison of CPAP vs BiPAP: Key Clinical Parameters
Item | CPAP | BiPAP |
Working Principle | Delivers constant single-level positive pressure to maintain airway patency only | Dual-level pressure: Inspiratory (IPAP) and expiratory (EPAP) support |
Pressure Mode | Single pressure (e.g., 10 cmH₂O) | Dual pressure (e.g., IPAP 15 / EPAP 5 cmH₂O); pressure gradient determines support |
Indications | OSA, mild hypoxemic respiratory failure (e.g., cardiogenic pulmonary edema) | Hypercapnic respiratory failure, AECOPD, neuromuscular disease, CPAP-failure OSA |
Comfort | Expiration against constant pressure; tolerance declines at higher pressures | Lower expiratory pressure improves comfort |
Trigger & Synchrony | No trigger; continuous flow only | Flow/pressure trigger with synchronized cycling; ST mode provides backup rate |
Tidal Volume Control | Cannot directly increase tidal volume | IPAP–EPAP gradient augments alveolar ventilation and CO₂ elimination |
Typical Use | Home or sleep lab—long-term nocturnal therapy | ED/ICU—bridging therapy for acute respiratory failure to avoid intubation |
Table: Core Performance Differences Between CPAP and BiPAP
After understanding the differences between CPAP and BIPAP in the technology principle, physicians must also ensure that disease symptoms align with device suitability. The following section details the various indications for CPAP therapy to assist clinicians in selecting appropriate treatment plans and reducing trial-and-error costs.
III.(Continuous Positive Airway Pressure) CPAP Therapy Indications
Continuous positive airway pressure (CPAP) therapy provides continuous, non-invasive airway pressure to the upper respiratory tract. It is primarily used to maintain upper airway patency and improve oxygenation in patients with various acute and chronic respiratory diseases. So, which diseases require CPAP? Which patients need CPAP? Next, we will discuss the following indications and when CPAP should be considered as a first-line or adjunctive therapy.
1.Obstructive Sleep Apnea (OSA)
The primary characteristic of OSA is the repeated collapse of soft tissues in the throat (soft palate, uvula, tongue) during sleep, leading to partial or complete obstruction of the upper airway, resulting in intermittent hypoxia and fragmented sleep.
Snoring, choking or wheezing sounds during sleep, and excessive daytime sleepiness are all prominent symptoms that patients typically report to their doctors. OSA affects up to 1 billion people aged 30 to 69 worldwide, with at least 10% of the population in the United States suffering from it.
The mechanism of CPAP therapy for OSA involves delivering a constant, titrated pressure throughout the respiratory cycle, providing the patient with a steady airflow during sleep to reduce the likelihood of airway collapse, thereby eliminating snoring and apneas.
Which symptoms of OSA require CPAP therapy?
a.Moderate to severe OSA (apnea-hypopnea index ≥ 15 events per hour).
b.Mild obstructive sleep apnea (OSA) accompanied by excessive daytime sleepiness, hypertension, or cardiovascular disease.
2.Cardiac Pulmonary Edema (acute decompensated heart failure)
Cardiogenic pulmonary edema (CPE) is a leading cause of acute respiratory failure (ARF) and frequently necessitates non-invasive ventilatory assistance.CPE is the accumulation of excess fluid in the lungs, which can be life-threatening.
This results from increased pressure on the left side of the heart and blood pooling, typically due to heart failure. In addition to shortness of breath, cardiac edema can lead to hypoxia-induced organ damage.
In patients with ARF caused by CPE, the use of non-invasive positive airway pressure ventilation can reduce systemic venous return and left ventricular (LV) afterload, thereby lowering LV filling pressure and limiting pulmonary edema. CPAP provides airway positive pressure ventilation, restoring functional residual capacity through alveolar recruitment, thereby reducing right-to-left pulmonary shunting and improving oxygenation and pulmonary mechanics.
This pressure increases functional residual capacity (FRC), which is the amount of air remaining in the lungs after a normal passive exhalation. Therefore, CPAP therapy can be introduced to promote greater gas exchange and improve oxygenation and ventilation, thereby reducing the patient’s workload. CPAP not only helps restore lung surface area expansion but also supports airways at risk of collapse due to excess fluid.
Compared to standard oxygen therapy, CPAP therapy reduces the need for endotracheal intubation and in-hospital mortality in patients with acute cardiogenic pulmonary edema.
Which symptoms of CPE require CPAP therapy?
a.Acute left ventricular failure with pulmonary edema, with maintained or elevated blood pressure; adjunct to diuretic and vasodilator therapy.
3.Hypoxic Respiratory Failure (in some cases)
Hypoxic respiratory failure refers to insufficient oxygen in the blood (hypoxemia). Pneumonia, early acute respiratory distress syndrome (ARDS), and postoperative atelectasis are the most common causes of hypoxic respiratory failure.
The primary mechanism of action of CPAP therapy is to supply oxygen to the lungs, maintain alveolar recruitment, and prevent alveolar collapse, thereby aiding in the clearance of carbon dioxide from the lungs. It provides pressure to prevent the small air sacs (alveoli) in the lungs from collapsing. By increasing functional residual capacity (FRC), it reduces respiratory effort.
Which symptoms of hypoxic require CPAP therapy?
a.Simple hypoxemia (e.g., pneumonia, early ARDS) when the patient retains spontaneous breathing ability. If the patient develops hypercapnia (CO₂retention) or respiratory muscle fatigue, upgrade to BiPAP or invasive ventilation.
4.Postoperative Respiratory Support
Up to 40 % of patients undergoing major abdominal surgery develop postoperative pulmonary complications (PPC), including atelectasis, pneumonia, and respiratory failure, leading to prolonged ICU and hospital stays. This high PPC rate increases the risk of postoperative readmission to the ICU or endotracheal intubation for mechanical ventilation, which prolongs hospital stays, increases the risk of nosocomial infections, and raises postoperative mortality rates.
Most PPCs are triggered by atelectasis, which causes functional loss of lung tissue due to collapsed alveoli. The primary cause is reduced diaphragmatic excursion during ventilation, leading to thoracic-dominant breathing, significantly reduced tidal volume (VT), and ultimately collapse of small airways. The triggering mechanism is postoperative abdominal pain, which often causes patients to adopt shallow breathing patterns, leading to collapse of dependent alveoli.
Continuous positive airway pressure (CPAP) is a non-invasive ventilation (NIV) modality that delivers constant positive airway pressure throughout the respiratory cycle. This positive pressure counters the restrictive pulmonary defect and prevents derecruitment of small airways.
Which symptoms of postoperative require CPAP therapy?
a.Temporary upper-airway obstruction secondary to airway edema or increased secretions following general anesthesia.
b.Prevention of atelectasis and hypoxemia in obese or morbidly obese patients postoperatively.
5.Other/Special Indications
a. Neonatal Respiratory Distress Syndrome (RDS)
Respiratory Distress Syndrome (RDS) is a condition caused by a deficiency or insufficiency of pulmonary surfactant and associated pulmonary developmental abnormalities. This condition primarily affects preterm infants (born before 37 weeks of gestation), characterized by progressively increasing respiratory effort, reduced airflow into the lungs, and resulting hypoxemia.
Nasal CPAP therapy maintains alveolar expansion, prevents alveolar collapse, and reduces the work of breathing.
b. Upper Airway Resistance Syndrome (UARS)
Upper Airway Resistance Syndrome (UARS) is a sleep-related breathing disorder caused by mild airway collapse, but it does not meet the diagnostic criteria for OSA. Some experts classify UARS as a condition intermediate between snoring and sleep apnea.
Therapies such as continuous positive airway pressure (CPAP) involve a machine gently delivering pressurized air into the upper airway via a circuit and mask interface. The positive airway pressure maintains airway patency and allows for normal breathing.
c. Mild Neuromuscular Disease (NMD)
Neuromuscular disease (NMD) comprises a heterogeneous group of disorders affecting the motor unit, leading to respiratory muscle weakness and impaired ventilation. The severity and progression of these diseases vary widely, resulting in hypoventilation, impaired secretion clearance, and sleep-disordered breathing.
CPAP therapy is indicated for individuals with mild NMD and concomitant obstructive sleep apnea. For patients with advanced NMD requiring augmented ventilatory support or those with significant hypoventilation (hypercapnia), bilevel PAP (BiPAP) is recommended.
For Medtribs
Continuous positive airway pressure (CPAP) therapy is often the ideal solution for patients with sleep apnea. We recommend Resvent iBreeze PAP (20A) CPAP machine features an intelligent progressive pressure adaptation algorithm, Intelligent Pressure Relief (IPR) technology, integrated heated humidification system, and event detection and recording to improve patient compliance, minimize adverse reactions, and accelerate the achievement of treatment goals.
To Sum Up
However, for patients with severe obstructive sleep apnea, central sleep apnea, or those diagnosed with other serious respiratory diseases, can CPAP still be used? What is the Bipap machine used for? For specific BiPAP treatment details, see—What are the indications for BiPAP therapy? (Ⅱ)
